Functional characterization of anergic helper T cells
Functional characterization of anergic helper T cells
批准号:
7166123
负责人:
Daniel L Mueller
金额:
$29.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2012-07-31
关键词:
AdjuvantAntigensAutoimmune DiseasesAutoimmunityCD28 geneCD4 Positive T LymphocytesCD8B1 geneCTLA4 geneCellsCellular ImmunologyClinicalClonal AnergyComputer Systems DevelopmentDataDefectDependenceDevelopmentEnsureEventFlow CytometryGenerationsGoalsGrantHealthHelper-Inducer T-LymphocyteIL2RA geneIL2RB geneImmuneImmune systemImmunocompetentIndividualInfectionInterleukin-2LymphopeniaMediatingMouse StrainsMusMutant Strains MiceNude MicePCNA genePathway interactionsPeripheralPhenotypePhosphorylationPopulationPrincipal InvestigatorProteinsRecoveryResearchResistanceRoleSignal PathwaySignal TransductionT memory cellT-Cell DevelopmentT-LymphocyteTestingTissuesTransgenesTransgenic OrganismsTransplantation ToleranceWorkanergyautoreactive T cellautoreactivitybasecyclin D3gain of functionhuman FRAP1 proteinhuman TGFB1 proteinimmunopathologyin vivomutantprogramsreconstitution
中文摘要
对于那些缺乏足够的AIRE依赖胸腺表达的组织特异性蛋白,以确保中央
耐受性,外周耐受性机制存在,以确保健康和避免自身免疫。在……里面
除了自我同意活性高的I细胞外,克隆性无能机制
可用于限制潜在的自身反应性T细胞的增殖潜力。此外,天然的CD4+
调节性T细胞聚集在外周,对T细胞产生逆调节作用
限制免疫病理学的反应性。在最近的赠款期间,我们发现在
严重的淋巴细胞减少(在没有调节性T细胞的情况下)克隆无能是不能诱导的,而
部分免疫重建后CD25+CD4+调节性T细胞促进小鼠诱导克隆性无能
在没有感染或佐剂的情况下识别抗原的T细胞。我们现在建议详细探讨这一问题--
CD_4~+调节性T细胞与诱导和/或逆转克隆性无能的关系
淋巴细胞减少和免疫活性免疫系统。具体地说,本申请旨在:1)定义
介导抵抗T细胞克隆性无能诱导及其逆转的细胞内信号事件
淋巴细胞减少的个体,2)早期识别促进CD4+调节性T细胞发育的分子
3)检测CD4+调节性T细胞之间的相互依赖关系
免疫活性个体T细胞克隆性无能的产生和诱导。数据生成自
这项工作将作为开发诱导移植的抗原特异性策略的基础
耐受或治愈临床自身免疫性疾病。
英文摘要
For those tissue-specific proteins that lack sufficient AIRE-dependent thymic expression to ensure central
tolerance, peripheral tolerance mechanisms exist to ensure health and the avoidance of autoimmunity. In
addition totheperipheral deletion ofI cells with high self Agreactivity, the clonal anergy mechanismis
available to limit the proliferative potential of potentially autoreactive T cells. Furthermore, natural CD4+
regulatory T cells accumulate in the periphery and exert a counter-regulatory influence on T cell
responsiveness to limit immunopathology. In the most recent grant period, we discovered that in the setting of
profound lymphopenia (and in the absence of regulatory T cells) clonal anergy cannot be induced, whereas
following partial immune reconstitution CD25+ CD4+ regulatory T cells facilitate the induction clonal anergy in
T cells that recognize Ag in absence of infection or adjuvant. We now propose to explore in detail this inter-
relationship between CD4+ regulatory T cells and the induction and/or reversal of clonal anergy in both the
lymphopenic and immunocompetent immune system. Specifically, this application seeks to: 1) define
intracellular signaling events that mediate a resistance to T cell clonal anergy induction and its reversal within
lymphopenic individuals, 2) identify molecules that promote the development CD4+ regulatory T cells early
during the recovery from lymphopenia, and 3) examine the inter-dependence of CD4+ regulatory T cell
generation and the induction of T cell clonal anergy in immunocompetent individuals. Data generatedfrom
this work will serve as the basis for the development of Ag-specific strategies to induce transplantation
tolerance or cure clinical autoimmune disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Medical Student Summer Research Program in Infection and Immunity
-
批准号:9097536
-
项目类别:
-
资助金额:$2.98万
-
财政年份:2015
-
负责人:Daniel L Mueller
-
依托单位:
Medical Student Summer Research Program in Infection and Immunity
-
批准号:10620608
-
项目类别:
-
资助金额:$4.71万
-
财政年份:2015
-
负责人:Daniel L Mueller
-
依托单位:
Functional characterization of anergic helper T cells
-
批准号:8308580
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2011
-
负责人:Daniel L Mueller
-
依托单位:
Epigenetic Control of T cell Autoimmunity
-
批准号:7914393
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2009
-
负责人:Daniel L Mueller
-
依托单位:
Epigenetic Control of T cell Autoimmunity
-
批准号:7727443
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2009
-
负责人:Daniel L Mueller
-
依托单位:
Immunobiology of Transplant Obliterative Disease
-
批准号:6383438
-
项目类别:
-
资助金额:$7.7万
-
财政年份:2001
-
负责人:Daniel L Mueller
-
依托单位:
FUNCTIONAL CHARACTERIZATION OF ANERGIC HELPER T CELLS
-
批准号:6340666
-
项目类别:
-
资助金额:$11.05万
-
财政年份:2000
-
负责人:Daniel L Mueller
-
依托单位:
FUNCTIONAL CHARACTERIZATION OF ANERGIC HELPER T CELLS
-
批准号:6201189
-
项目类别:
-
资助金额:$11.05万
-
财政年份:1999
-
负责人:Daniel L Mueller
-
依托单位:
FUNCTIONAL CHARACTERIZATION OF ANERGIC HELPER T CELLS
-
批准号:6099754
-
项目类别:
-
资助金额:$11.05万
-
财政年份:1998
-
负责人:Daniel L Mueller
-
依托单位:
FUNCTIONAL CHARACTERIZATION OF ANERGIC HELPER T CELLS
-
批准号:6235200
-
项目类别:
-
资助金额:$10.74万
-
财政年份:1997
-
负责人:Daniel L Mueller
-
依托单位:
Functional characterization of anergic helper T cells
-
批准号:10688015
-
项目类别:
-
资助金额:$35.91万
-
财政年份:1997
-
负责人:Daniel L Mueller
-
依托单位:
Functional characterization of anergic helper T cells
-
批准号:10466848
-
项目类别:
-
资助金额:$36.42万
-
财政年份:1997
-
负责人:Daniel L Mueller
-
依托单位:
REGULATION OF IL-2 GENE EXPRESSION IN T CELL ANERGY
-
批准号:6324468
-
项目类别:
-
资助金额:$7.23万
-
财政年份:1996
-
负责人:Daniel L Mueller
-
依托单位:
Regulation of IL-2 Gene Expression in T-cell Anergy
-
批准号:6838137
-
项目类别:
-
资助金额:$29.7万
-
财政年份:1996
-
负责人:Daniel L Mueller
-
依托单位:
REGULATION OF IL-2 GENE EXPRESSION IN T CELL ANERGY
-
批准号:2444908
-
项目类别:
-
资助金额:$19.42万
-
财政年份:1996
-
负责人:Daniel L Mueller
-
依托单位:
REGULATION OF IL-2 GENE EXPRESSION IN T CELL ANERGY
-
批准号:6019189
-
项目类别:
-
资助金额:$20.46万
-
财政年份:1996
-
负责人:Daniel L Mueller
-
依托单位:
Regulation of IL-2 Gene Expression in T-cell Anergy
-
批准号:6692660
-
项目类别:
-
资助金额:$29.7万
-
财政年份:1996
-
负责人:Daniel L Mueller
-
依托单位:
REGULATION OF IL-2 GENE EXPRESSION IN T CELL ANERGY
-
批准号:2194043
-
项目类别:
-
资助金额:$18.26万
-
财政年份:1996
-
负责人:Daniel L Mueller
-
依托单位:
Regulation of IL-2 Gene Expression in T-cell Anergy
-
批准号:6621934
-
项目类别:
-
资助金额:$29.7万
-
财政年份:1996
-
负责人:Daniel L Mueller
-
依托单位:
Regulation of IL-2 Gene Expression in T-cell Anergy
-
批准号:6437877
-
项目类别:
-
资助金额:$29.7万
-
财政年份:1996
-
负责人:Daniel L Mueller
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: